In what it could be a piece of good news, a biotechnology company that is conducting clinical trials to manufacture a vaccine to treat Covid-19 announced that its vaccine is 94.5 percent effective in preventing the pandemic.
Reports claim that the investigational vaccine candidate developed by US-based Moderna provided to be as much as 94.5 percent effective in preventing the ongoing pandemic.
The interim data from the US-based company came when the Global toll of the Covid-19 virus is inching towards the 55 million mark and all the eyes are on the vaccine to cure the pandemic.
Moderna is the second drugmaker to announce its vaccine to achieve more than 90 percent effectiveness in curing the pandemic. Earlier, the vaccine candidate developed by Pfizer and BioNTech was found to be more than 90 percent in the interim analysis.
It is beloved that the interim analysis by Moderna was based on observations from 95 trial participants who took the vaccine dose. The participants have received two vaccine doses within a gap of 28 days.
Well, two companies claiming vaccine candidates developed by them achieving more than 90 percent of efficiency is certainly good news for the world. Let's hope that the vaccine is rolled out very soon.
Reports claim that the investigational vaccine candidate developed by US-based Moderna provided to be as much as 94.5 percent effective in preventing the ongoing pandemic.
The interim data from the US-based company came when the Global toll of the Covid-19 virus is inching towards the 55 million mark and all the eyes are on the vaccine to cure the pandemic.
Moderna is the second drugmaker to announce its vaccine to achieve more than 90 percent effectiveness in curing the pandemic. Earlier, the vaccine candidate developed by Pfizer and BioNTech was found to be more than 90 percent in the interim analysis.
It is beloved that the interim analysis by Moderna was based on observations from 95 trial participants who took the vaccine dose. The participants have received two vaccine doses within a gap of 28 days.
Well, two companies claiming vaccine candidates developed by them achieving more than 90 percent of efficiency is certainly good news for the world. Let's hope that the vaccine is rolled out very soon.